Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination program | Zendy

Varisara Ngaovithunvong | Zendy; Nasamon Wanlapakorn | Zendy; Lita Tesapirat | Zendy; Narrissara Suratan | Zendy; Yong Poovorawan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination program

Author(s) -

Varisara Ngaovithunvong,

Nasamon Wanlapakorn,

Lita Tesapirat,

Narrissara Suratan,

Yong Poovorawan

Publication year - 2016

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.7560

Subject(s) - medicine , measles , vaccination , rubella , mmr vaccine , seroprevalence , measles mumps rubella vaccine , mumps vaccine , pediatrics , population , incidence (geometry) , booster dose , rubella vaccine , demography , immunization , immunology , serology , antibody , environmental health , physics , sociology , optics

mumps vaccination implementation in the form of MMR - measles, mumps, and rubella) in Thailand for first-grade school students since 1997 and for infants 9-12 months of age since 2010 resulted in a dramatic decline in the incidence of and deaths from mumps. However, there has been a resurgence of mumps outbreaks in Thailand, even in vaccinated populations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research